Wei Guanghui, member of the Party Leadership Group and Deputy Director of the Guangxi Administration for Drug Supervision, visited our company to inspect and guide our efforts in ensuring the supply of epidemic prevention and medical materials during the Spring Festival.

Release date:

2021-01-24

On January 21, Wei Guanghui, member of the Party Leadership Group and Deputy Director of the Guangxi Administration for Drug Supervision, along with Gao Hui, Director of the Production Supervision Division, led a research team to conduct an in-depth investigation at Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd., providing guidance to the pharmaceutical manufacturer on fully ensuring the supply of epidemic prevention and medical supplies as well as maintaining quality and safety during the Spring Festival period.

1 On the 21st, Wei Guanghui, member of the Party Leadership Group and Deputy Director of the Guangxi Administration for Drug Supervision, along with Gao Hui, Director of the Production Supervision Division, led a research team to conduct an in-depth investigation at Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd., providing guidance to the pharmaceutical manufacturer on fully ensuring the supply of epidemic prevention and medical supplies as well as maintaining quality and safety during the Spring Festival period.

The research team thoroughly inspected the warehouses for production raw materials and excipients, as well as the oral liquid and injectable drug production facilities, gaining detailed insights into the company's operations—including production, sales, technological innovation, and market development. They highly praised our company for its boldness in embracing innovation, its proactive approach to practical implementation, and its strong sense of social responsibility. In particular, they commended the company for its proactive efforts during the epidemic prevention and control period—resuming, shifting, and expanding production to manufacture critical medical supplies such as disinfectant alcohol and antiviral formulations. Additionally, the team clearly emphasized the importance of continuing to ensure both product quality and supply stability.

Wei Guanghui, member of the Party Leadership Group and Deputy Director of the Guangxi Administration for Drug Supervision, emphasized: "Currently, the global pandemic continues to escalate, and the risk of locally transmitted cases caused by imported infections is on the rise. As the Spring Festival approaches, population mobility will increase significantly, and cluster outbreaks have already occurred in some regions. We must fully recognize the complexity of epidemic prevention and control during the Spring Festival period, resolutely overcome complacency and侥幸心理 (a sense of luck or underestimation of risks), remain highly vigilant, and closely align our efforts with actual needs, ensuring robust and effective supply of防疫 medical materials."

One is Pharmaceutical manufacturers must elevate their political awareness, accelerate production, increase reserves, and do their utmost to ensure the supply of medical materials for epidemic prevention and control, effectively meeting the needs of Guangxi's COVID-19 response efforts.

Second, We must actively implement the primary responsibilities of enterprises, strengthen production and quality management, ensure product quality is safe, effective, and efficient, and provide robust support for epidemic prevention and control efforts.

Third, Drug regulatory authorities must strengthen enforcement efforts, intensify supervision and inspection, crack down on illegal and non-compliant activities, and do their utmost to ensure the quality and safety of medical supplies for epidemic prevention and control, guaranteeing that people across the region can safely, happily, and peacefully enjoy the festive season.

Congratulations! Baihui Pharmaceutical's Aluminum Magnesium Carbonate Chewable Tablets Have Passed Consistency Evaluation

Wei Haopeng, Secretary of the Party Leadership Group of Nanning Municipal Ecology and Environment Bureau, and his delegation visited Baihui Pharmaceutical to hold a symposium on follow-up services for enterprises.